These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20413225)

  • 1. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data.
    Martin LM; Marples B; Coffey M; Lawler M; Lynch TH; Hollywood D; Marignol L
    Cancer Treat Rev; 2010 Nov; 36(7):518-27. PubMed ID: 20413225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
    Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
    Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways.
    Zeng M; Narayanan L; Xu XS; Prolla TA; Liskay RM; Glazer PM
    Cancer Res; 2000 Sep; 60(17):4889-93. PubMed ID: 10987303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
    Gurkan E; Schupp JE; Aziz MA; Kinsella TJ; Loparo KA
    Cancer Res; 2007 Nov; 67(22):10993-1000. PubMed ID: 18006845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
    Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
    Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
    Fedier A; Fink D
    Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
    Yamane K; Schupp JE; Kinsella TJ
    Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L5178Y sublines: a look back from 40 years. Part 2: response to ionizing radiation.
    Szumiel I
    Int J Radiat Biol; 2005 May; 81(5):353-65. PubMed ID: 16076750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
    Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
    Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-tumor cells from an MSH2-null individual show altered cell cycle effects post-UVB.
    Narine KA; Felton KE; Parker AA; Tron VA; Andrew SE
    Oncol Rep; 2007 Dec; 18(6):1403-11. PubMed ID: 17982623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of O6MeG lesions by MGMT and mismatch repair proficiency may be a prerequisite for low-dose radiation hypersensitivity.
    Martin L; Marples B; Coffey M; Lawler M; Hollywood D; Marignol L
    Radiat Res; 2009 Oct; 172(4):405-13. PubMed ID: 19772461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell cycle and DNA mismatch repair.
    Schroering AG; Edelbrock MA; Richards TJ; Williams KJ
    Exp Cell Res; 2007 Jan; 313(2):292-304. PubMed ID: 17157834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation.
    Bristow RG; Hu Q; Jang A; Chung S; Peacock J; Benchimol S; Hill R
    Oncogene; 1998 Apr; 16(14):1789-802. PubMed ID: 9583677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the "mismatch repairosome" and its role in the processing of modified nucleosides in vitro.
    Baerenfaller K; Fischer F; Jiricny J
    Methods Enzymol; 2006; 408():285-303. PubMed ID: 16793376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
    Kaina B; Christmann M; Naumann S; Roos WP
    DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage.
    Aquilina G; Crescenzi M; Bignami M
    Carcinogenesis; 1999 Dec; 20(12):2317-26. PubMed ID: 10590226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.